Drug-Induced and Iatrogenic Respiratory Disease

At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work with an outstanding range of international expert contributors and two of the world’s leading editors, provides an essential reference for the practising respiratory physician. Key features: • The text builds upon basics with a review of basic sciences. • The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease • A wide range of diseases are detailed from chemotherapy and radiation to biologic-induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants. • A range of world class contributions from key opinion leaders. This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians. * Builds upon basics with a review of basic sciences * The book covers imaging, interstitial disease, chest symptoms and respiratory failure * A wide range of diseases are detailed from chemotherapy and radiation to drug misuse, the respiratory effects of neurological drugs and special groups such as pediatric drug-induced respiratory disease * A range of world class contributions from key opinion leaders Table of Contents: 1. Drug-induced respiratory disease: classification, diagnosis, and management 2. Mechanisms of chemically induced respiratory toxicities 3. Imaging of Drug-induced Lung Disease 4. Bronchoalveolar Lavage in Drug-induced lung disease 5. Pathology of drug-induced respiratory disease 6. Drug Allergy in Lung Disease I - DRUG-INDUCED RESPIRATORY EMERGENCIES 7. Drug-induced upper-airway obstruction 8. Drug-induced bronchospasm 9. Drug-induced pulmonary oedema and acute respiratory distress syndrome 10. Pulmonary complications of Blood Transfusion 11. Drug-Induced alveolar haemorrhage 12. Pulmonary complications of illicit drug use 13. Iatrogenic tracheobronchial and chest injury II - ONCOLOGY AND ALLIED CONDITIONS 14. Pulmonary reactions to chemotherapeutic agents: The “chemotherapy lung” 15. Pulmonary reactions to novel chemotherapeutic agents and biomolecules 16. Radiation-induced lung disease 17. Pulmonary complications of bone-marrow and stem-cell transplantation 18. Pulmonary complications of solid organ transplantation 19. Pulmonary infection induced by drugs 20. Therapy-induced neoplasms III - NON-ONCOLOGICAL CONDITIONS 21. Pneumonitis induced by noncytotoxic agents 22. Amiodarone pulmonary toxicity 23. Eosinophilic pneumonia induced by drugs 24. Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy 25. Coughing induced by drugs 26. Pleural disease induced by drugs 27. Lupus erythematosus syndrome induced by drugs 28. Vasculitis induced by drugs 29. Pulmonary hypertension induced by drugs and toxins 30. Respiratory involvement from herbals About the Author(s): Philippe Camus, MD is Professor of Pulmonary Medicine, Department of Pulmonary and Critical Care Medicine, Hôpital du Bocage and Université de Bourgogne, Dijon, France Edward C Rosenow III, MD, MS, MACP, Master FCCP is Emeritus Professor of Medicine, Former Chair Division of Pulmonary and Critical Care Medicine, Mayo Distinguished Clinician, Mayo Clinic School of Medicine, Rochester, Minnesota, USA Contributors: Lucien Abenhaim, LARISK Consultants, School of Hygiene and Tropical Medicine, London, UK; Bekele Afessa, Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA; James N Allen, Division of Pulmonary and Critical Care Medicine, Ohio State University, Columbus, OH, USA; Noreen Aziz, Rubin Center for Cancer Survivorship, James P Wilmot Cancer, Center, University of Rochester Medical Center, Rochester, NY, USA; K Suresh Babu, Infection, Inflammation and Repair, Southampton General Hospital, Southampton, UK; Andrew D Badley, Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA; Francesco Bonella, Ruhrlandklinik, Department of Pneumology/Allergy, Essen, Germany; Kim Bouillon, Department of Epidemiology and Public Health